Prevention and Management of Complications in LASIK Surgery

Volume 34, Number # 4, 2006 Series

1. Pallikaris IG, Kymionos GD, Astyrakakis NI. Corneal ectasia induced by laser in situ keratomileusis. J Cataract Refract Surg 2001; 27:1796-1802.

2. Comaish IF, Lawless MA. Progressive post-LASIK keratectasia, biomechanical instability or chronic disease process?. J Cataract Refract Surg 2002; 28:2206-2213.

3. Kohnen T. From the editor: Iatrogenic keratectasia: Current knowledge, current measurements. J Cataract Refract Surg 2002; 28:2265.

4. Salomon K. Determining how your keratome cuts. Eeworld, april 8, 2003, page 38.

5. Ou RJ, Shaw EL, Glasgow BJ. Keratectasia after Laser in situ keratomileusis (LASIK): Evaluation of the calculated residual stromal bed thickness. Am J Ophthalmol 2002; 134:771-773.

6. Fogla R, Rao SK, Padmanabhan P. Keratectasia in 2 cases with pellucid marginal corneal degeneration after laser in siu keraomileusis. J Cataract Refract Surg 2003; 29:788-791.

7. Wang JC, Hufnagel tJ, Buton DF. Bilateral keraecasia after unilateral laser in siu keraomileusis: A retrospective diagnosis of ectatic corneal disorder. J Cataract Refract Surg 2003; 29:2015-2018.

8. Choi HJ, Kim MK, Lee JL. Optimization of Contac lens fitting in keratectasia patients after laser in siu keraomileusis. J Cataract Refract Surg 2004; 30:1057-1066.

9. Alio JL, Salem F, Arola A, Osman AA. Inracorneal rings o correct corneal ectasia after laser in siu keraomileusis. J Cataract Refract Surg 2002; 28:1568-1574.

10. Kohlhaas M, Spoerl E, Speck A, Schilde , Sandner D, Pilluna LE. A new t reament of keratectasia after LASIK with riboflavin/UVA light cross-linking. Klin Monasbl Augenheilkd 2005; 22(5):430-436.

11. Battat L, Macri A, Dursun D, Pflugfelder SC. Effects of Laser-Assisted In Situ Keratomileusis on Tear Production, Clearance, and the Ocular Surface. Ophthalmol 108(7):1230-1235.

12. Donnenfled ED, Ehrenhaus M, Solomon R et al. Effect of hinge width on corneal sensation and dry eye after laser in situ keratomileusis. J Cataract Refract Surg April 2004; (30); 790-797.

13. Toda I, Asano-Kato N, Hori-Komai Y, Tsubota K. Laser-Assisted In Situ Keratomileusis for Patients with Dry Eye. Arch Ophthalmol August 2002; 120:1024-1028.

14. Albietz JM, Lenton LM, McLennan SG. Chronic Dry Eye and Regression after Laser in situ Keratomileusis for myopia. J Cataract Refract Surg; Mar 2004 (30):675-684.

15. Lindstrom RL, Hardten DR, Chu YR. Laser In Situ Keratomileusis (LASIK) for the treatment of low, moderate and high myopia. Trans Am Ophthalmol Soc 1997; (95): 285-296.

16. Chayet AS, Magallanes R, Montes M, et al. Laser in situ Keratomileusis (LASIK) for simple myopic, mixed and simple hyperopic astigmatism. J Refract Surg 1998; (14): S175-176.

17. Smith RJ, Maloney RK. Diffuse Lamellar Keratitis: a new syndrome in lamellar refractive surgery. Ophthalmol 1998; 105:1721-1726.

18. Johnson JD, Azar DT. Diffuse lamellar keratitis: incidence, associations, outcomes, and a new classification system. J Cataract Refract Surg 2001; 27:1560-1566.

19. Machat JJ. The Art of LASIK. Thorofare, NJ. Slack. 1999; Chapter 32: 393-396.

20. Linebarger EJ, Hardten DR. Diffuse Lamellar Keratitis: Diagnosis and management. J Cataract Refract Surg 2000; 26: 1072-1077.

21. Hoffman RS, Fine IH, Packer M, Reynolds TP, Bebber CV. Surgical Glove-Associated Diffuse Lamellar Keratitis. Cornea. 2005 Aug;24(6):699-704.

22. Morck DW, Holland SP, Ceri H et al. Use of Polymyxin as an endotoxin blocker in the prevention of diffuse lamellar keratitis in an animal model. J Refract Surg 2005 April (2): 152-157.

23. Hoffman RS, Fine IH, Packer M. Incidence and outcomes of lasik with diffuse lamellar keratitis treated with topical and oral corticosteroids. J Cataract Refract Surg 2003 Mar 29(3): 451-456.

24. Alio JL, Perez-Santonja JJ, Tervo T et al. Postoperative inflammation, microbial complications, and wound healing following laser in situ keratomileusis. J Refract Surg. 2000 Sep-Oct;16(5):523-38.

25. Wilson SE, Ambrosio R. Laser In Situ Keratomileusis-Induced neurotrophic Epitheliopathy. Am J Ophthalmol 2001 Sep;132 (3):405-406.

26. Perry HD, Donnenfeld ED. Dry Eye Diagnosis and Management in 2004. Curr Opin Ophthalmol, 2004; 15:299-304.

27. Christensen MT, Cohen S, Rinehart J, Akers F, Pemberton B, Bloomenstein M, Lesher M, Kaplan D, Meadows D, Meuse P, Hearn C, Stein JM. Clinical Evaluation of an HP-guar Gellable Lubricant Eye Drop for the Relief of Dryness of the Eye. Curr Eye Res. 2004. Jan;28(1):55-62.

28. Christensen MT, J.M Stein, R,P. Stone, D.L. Meadows. Evaluation of the Effect on Tear Film Break-up Time Extension by Artificial Tears in Dry Eye Patients. Abstract Presented at 23rd Biennial Cornea Research Conference. Oct.3-4, 2003.

29. Huang B, Mirza MA, Qazi MA, Pepose JS. The effect of punctual occlusion on wavefront aberrations in dry eye patients after laser in situ keratomileusis. Am J Ophthalmol; Jan 2004:137(1)52-61.

30. Small DS, Acheanpong A, Reis B, et al. Blood concentrations of cyclosporine A during long-term treatment with cyclosporine A Ophthalmic emulsions with moderate to severe dry eye disease. J Ocul Pharmacol Ther; 2002,18:411.

31. Kunert KS, Tisdal AS, Gibson IK. Goblet cell numbers and Epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine 2. Arch Ophthalmol 2002;120:330-337.

32. Hori Y, Spurr-Michaud S, Russo CL, et al. Differential Regulation of Membrane-Associated Mucins in the human Ocular Surface Epithelium. Invest Ophthalmol Vis Sci 2004;45:112-117.

33. Perry HD, Doshi S, Donnenfeld ED, et al. Double-Masked randomized controlled study evaluating topical 0.05% cyclosporine A in the treatment of Meibomian gland dysfunction (posterior blepharitis). Invest Ophthalmol Vis Sci 2003; 44:E.

34. Tsubota K, Goto E, Fujita H, et al. Treatment of dry eye by autologous serum preparation in Sjogren syndrome. Br J Ophthalmol 1999, 83: 390-395.

35. Tsubota K, Goto E, Shimmura H, et al. Treatment of persistent corneal epithelial defect by autologous serum application. Ophthalmol 1999, 106:1984-1989.

36. Kanade VG, Ramos-Esteban JC, Tauber S. Contamination rate of autologus serum for management of ocular surface disorders leading to dry eye. IOVS suppl April 2004.

37. Solomon R, Donnenfeld ED, Azar DT, et al. Infectious keratitis after laser in situ keratomileusis: results of an ASCRS survey. J Cataract Refract Surg 2003; 29:2001-2006.

38. Chung MS, Pepose JS, Al-Agha S et al. Confocal microscopic findings in a case of delayed-onset bilateral diffuse lamellar keratitis after laser in Situ Keratomileusis. J Cataract Refract Surg 2002; (28):1467-1470.

39. Rubinfeld RS, Negvesky GJ. Methicillin-resistant Staphylococcus aureus ulcerative keratitis after laser in situ keratomileusis. J Cataract Refract Surg 2001; 27:1523-1525.